What is a normal bilirubin level in a newborn?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Normal Bilirubin Levels in Newborns

Normal bilirubin levels in newborns vary significantly by age in hours, with physiologic jaundice typically resolving by 1-2 weeks in healthy term infants; direct/conjugated bilirubin is considered abnormal when it exceeds 1.0 mg/dL if total serum bilirubin is ≤5 mg/dL. 1, 2

Age-Specific Considerations

The definition of "normal" bilirubin in newborns is highly dependent on postnatal age and must be interpreted using hour-specific nomograms rather than single cutoff values:

First 24 Hours of Life

  • Jaundice appearing in the first 24 hours is considered pathologic until proven otherwise and requires immediate evaluation 3
  • A bilirubin level of 5 mg/dL at 10 hours is almost certainly pathologic, whereas the same level at 23 hours may be within normal limits 3
  • First-day bilirubin levels <6 mg/dL have a 97.9% negative predictive value for developing significant hyperbilirubinemia later 4

Days 2-5 of Life

  • Bilirubin levels are considered significant (requiring phototherapy) when they reach:
    • ≥12 mg/dL on day 2 5
    • ≥15 mg/dL on day 3 5
    • ≥17 mg/dL on days 4-5 5, 4
  • Physiologic jaundice in healthy term newborns typically resolves by 1-2 weeks of age 2

Beyond 2-3 Weeks

  • Any jaundice persisting beyond 3 weeks requires measurement of total and direct/conjugated bilirubin to identify potential cholestasis 2
  • Approximately one-third of normal breastfed infants remain clinically jaundiced at 2 weeks, but this should still prompt evaluation if it persists to 3 weeks 3

Risk Zone Classification

The American Academy of Pediatrics uses percentile-based risk zones to predict which newborns will develop significant hyperbilirubinemia 1:

  • High-risk zone: >95th percentile for age in hours
  • High-intermediate risk zone: 75th-95th percentile
  • Low-intermediate risk zone: 40th-75th percentile
  • Low-risk zone: <40th percentile

Infants in the low-risk zone before discharge had a 0% incidence of subsequently developing bilirubin levels >95th percentile 1

Direct/Conjugated Bilirubin Thresholds

Direct or conjugated bilirubin >1.0 mg/dL is abnormal when total serum bilirubin is ≤5 mg/dL 1, 2. This threshold is critical for identifying cholestatic conditions that require different management than unconjugated hyperbilirubinemia.

Important Clinical Caveats

Premature and Late-Preterm Infants

  • Infants at 35-37 weeks gestation should not be treated as full-term 3
  • These infants are four times more likely to have bilirubin >13 mg/dL than 40-week infants 3
  • They require closer monitoring and should not be discharged before 48 hours 3

Hemolytic Disease Risk Factors

  • G6PD deficiency can cause late-rising bilirubin and requires intervention at lower levels 1, 3
  • ABO incompatibility with positive direct antiglobulin test significantly increases risk 5
  • Reticulocyte count >4% and sibling history of neonatal jaundice are predictive of significant hyperbilirubinemia 5

Measurement Considerations

  • Visual estimation of jaundice is unreliable; laboratory measurement is essential 2
  • Laboratory measurement of direct bilirubin is imprecise and varies widely between laboratories 1, 6
  • Almost all outcome data are based on capillary blood samples, not venous 1

When to Worry

Bilirubin is considered pathologic and requires urgent evaluation when 7, 3:

  • Present within first 24 hours
  • Rising >5 mg/dL per day (>0.5 mg/dL per hour) 7, 5
  • Total bilirubin >17 mg/dL at any age 7
  • Accompanied by signs of illness
  • Persisting beyond 3 weeks of age 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.